Spread of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates Producing NDM-Type Metallo-β-Lactamase in Myanmar
暂无分享,去创建一个
T. Kirikae | S. Mya | Y. Tabe | T. Miida | T. Tada | Y. Lu | S. Misawa | M. Tohya | Htay Htay Tin | S. Takei | Shin Watanabe
[1] M. Doumith,et al. Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam , 2021, Scientific Reports.
[2] S. Hamada,et al. Characterization of bla NDM-5-harbouring Klebsiella pneumoniae sequence type 11 international high-risk clones isolated from clinical samples in Yangon General Hospital, a tertiary-care hospital in Myanmar. , 2021, Journal of medical microbiology.
[3] Zhen Shen,et al. Dissemination and Stability of the blaNDM-5-Carrying IncX3-Type Plasmid among Multiclonal Klebsiella pneumoniae Isolates , 2020, mSphere.
[4] Nyein Chan Soe Win,et al. Prevalence of Extended-Spectrum Beta-Lactamase/Carbapenemase Genes and Quinolone-Resistance Determinants in Klebsiella pneumoniae Clinical Isolates from Respiratory Infections in Myanmar. , 2020, Microbial Drug Resistance.
[5] M. Pervin,et al. Emergence of Mobile Colistin Resistance (mcr-8) in a Highly Successful Klebsiella pneumoniae Sequence Type 15 Clone from Clinical Infections in Bangladesh , 2020, mSphere.
[6] Hong Zhang,et al. Dissemination of the blaNDM-5 Gene via IncX3-Type Plasmid among Enterobacteriaceae in Children , 2020, mSphere.
[7] J. Campos,et al. Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS. , 2019, The Journal of antimicrobial chemotherapy.
[8] S. Hamada,et al. Dissemination of carbapenemase-producing Enterobacteriaceae harbouring blaNDM or blaIMI in local market foods of Yangon, Myanmar , 2019, Scientific Reports.
[9] J. Fehr,et al. Polyclonal gut colonization with extended-spectrum cephalosporin- and/or colistin-resistant Enterobacteriaceae: a normal status for hotel employees on the island of Zanzibar, Tanzania. , 2019, The Journal of antimicrobial chemotherapy.
[10] S. Hamada,et al. Spreading Patterns of NDM-Producing Enterobacteriaceae in Clinical and Environmental Settings in Yangon, Myanmar , 2018, Antimicrobial Agents and Chemotherapy.
[11] S. Hamada,et al. Genomic Characterization of Carbapenemase-Producing Klebsiella pneumoniae with Chromosomally Carried blaNDM-1 , 2018, Antimicrobial Agents and Chemotherapy.
[12] J. Chun,et al. A large-scale evaluation of algorithms to calculate average nucleotide identity , 2017, Antonie van Leeuwenhoek.
[13] Young Bae Kim,et al. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods , 2016, Front. Microbiol..
[14] Tom Slezak,et al. kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome , 2015, Bioinform..
[15] P. Nordmann,et al. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance , 2015, Antimicrobial Agents and Chemotherapy.
[16] Thierry Naas,et al. Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.
[17] G. Eliopoulos,et al. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[19] M. Yasuda,et al. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae , 1997, Antimicrobial agents and chemotherapy.